Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata

Ying Chen; Qiuyun Xu; Xiaoqing Lv; Zeyu Zhuang; Siyi Bao; Jing Mao; Ting Gong; Chao Ji

doi:10.1093/ced/llae548

Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata

Clin Exp Dermatol. 2024 Dec 21:llae548. doi: 10.1093/ced/llae548. Online ahead of print.

Authors

Ying Chen^{1

2}, Qiuyun Xu^{1

3

4}, Xiaoqing Lv^{1

3

4}, Zeyu Zhuang^{1

3

4}, Siyi Bao^{1

3

4}, Jing Mao^{1

3

4}, Ting Gong^{3

5}, Chao Ji^{1

3

4}

Affiliations

¹ Department of Dermatology, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Fuzhou, Fujian, China.
² Department of Dermatology, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China.
³ Fujian Dermatology and Venereology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
⁴ Key Laboratory of Skin Cancer of Fujian Higher Education Institutions, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
⁵ Central Laboratory, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Fuzhou, Fujian, China.

PMID: 39707907
DOI: 10.1093/ced/llae548

No abstract available